PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pelago Bioscience AB, Solna, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/2472555220973597
?:hasPublicationType
?:journal
  • SLAS discovery : advancing life sciences R & D
is ?:pmid of
?:pmid
?:pmid
  • 33208020
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all